inhibidores glp 1 Agonistas del receptor de péptido similar al glucagón tipo (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo 🧬 Inhibidores de la GLP-1

announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy (semaglutide) with Novo Nordisk.

Theres not a direct link between the medication for diabetes, hair loss, and shedding, but they happen.

As tirzepatide and other GLP-1based therapies continue to dominate headlines, this study offers an important glimpse at where the future of inflammatory disease treatment may be headed

But if you actually read the methodology, you realize we are being sold an illusion

Korean pharmaceutical and biotech companies are heading to the American Diabetes Association (ADA) 2026 Scientific Sessions with obesity and metabolic disease pipelines that reflect the industry's shift beyond simple weight loss toward muscle preservation, management of metabolic comorbidities and m

With a plethora of mixed opinions about whether or not they should be prescribed and a good amount of misinformation about side effects and risks, it can be a highly political and confusing landscape